| Literature DB >> 31810074 |
Eline-Claire Grosfeld1, Brandon T Smith, Marco Santoro, Irene Lodoso-Torrecilla, John A Jansen, Dietmar Jo Ulrich, Anthony J Melchiorri, David W Scott, Antonios G Mikos, Jeroen J J P van den Beucken.
Abstract
Here, we demonstrate the in vivo efficacy of glucose microparticles (GMPs) to serve as porogens within calcium phosphate cements (CPCs) to obtain a fast-degrading bone substitute material. Composites were fabricated incorporating 20 wt% GMPs at two different GMP size ranges (100-150 μm (GMP-S) and 150-300 μm (GMP-L)), while CPC containing 20 wt% poly(lactic-co-glycolic acid) microparticles (PLGA) and plain CPC served as controls. After 2 and 8 weeks implantation in a rat femoral condyle defect model, specimens were retrieved and analyzed for material degradation and bone formation. Histologically, no adverse tissue response to any of the CPC-formulations was observed. All CPC-porogen formulations showed faster degradation compared to plain CPC control, but only GMP-containing formulations showed higher amounts of new bone formation compared to plain CPC controls. After 8 weeks, only CPC-porogen formulations with GMP-S or PLGA porogens showed higher degradation compared to plain CPC controls. Overall, the inclusion of GMPs into CPCs resulted in a macroporous structure that initially accelerated the generation of new bone. These findings highlight the efficacy of a novel approach that leverages simple porogen properties to generate porous CPCs with distinct degradation and bone regeneration profiles.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31810074 PMCID: PMC7683932 DOI: 10.1088/1748-605X/ab5f9c
Source DB: PubMed Journal: Biomed Mater ISSN: 1748-6041 Impact factor: 3.715